• 대한두경부종양학회:학술대회논문집
• /
• 대한두경부종양학회 2005년도 제22차 추계학술대회
• /
• pp.228-228
• /
• 2005

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 2001년도 제40차 춘계학술대회 및 연수교육
• /
• pp.19-23
• /
• 2001

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 2002년도 제41차 추계학술대회
• /
• pp.7-8
• /
• 2002

• 대한두경부종양학회:학술대회논문집
• /
• 대한두경부종양학회 2006년도 추계학술대회 논문집
• /
• pp.211-211
• /
• 2006

• 대한의생명과학회지
• /
• 제8권2호
• /
• pp.53-62
• /
• 2002

• 대한두경부종양학회:학술대회논문집
• /
• 대한두경부종양학회 2009년도 추계학술대회 논문집
• /
• pp.184-184
• /
• 2009

• 한국원자력학회:학술대회논문집
• /
• 한국원자력학회 2005년도 춘계학술발표회
• /
• pp.963-963
• /
• 2005

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 The 5th Biannual Meeting of Pacific Rim Society for Fertility and Sterility
• /
• pp.60-61
• /
• 2006

• The Journal of Korean Physical Therapy
• /
• 제13권2호
• /
• pp.257-264
• /
• 2001

To take the Far-infrared(FIR) ray which is a optimized wavewlength and strength, at first, it is to be induced the characteristic algorithm and the computerized programing of FlR radiating materials. In this study, we induced that the formular of optimized FIR with physical, mathematical logic and theory, especially, Plank, Kirchhoff, Wien, Stefan-Boltzmann's logic and law. In the long run the formular was induced with mathematical integration. since we had to know the molecular wavelength. Base on the induced formular as above, we programmed the optimized FlR radiating computerized program, it would be useful to design semiconductor( VLSI) as the FlR instrument center control system.

• BMB Reports
• /
• 제43권12호
• /
• pp.773-780
• /
• 2010

Cancers are still difficult targets despite recent advances in cancer therapy. Due to the heterogeneity of cancer, a single-treatment modality is insufficient for the complete elimination of cancer cells. Therapeutic strategies from various aspects are needed. Gene therapy has been expected to bring a breakthrough to cancer therapy, but it has not yet been successful. Gene therapy also should be combined with other treatments to enhance multiple therapeutic pathways. In this view, gene delivery vector itself should be equipped with intrinsic anti-cancer activities. HVJ (hemagglutinating virus of Japan; Sendai virus) envelope vector (HVJ-E) was developed to deliver therapeutic molecules. HVJ-E itself possessed anti-tumor activities such as the generation of anti-tumor immunities and the induction of cancer-selective apoptosis. In addition to the intrinsic anti-tumor activities, therapeutic molecules incorporated into HVJ-E enabled to achieve multi-modal therapeutic strategies in cancer treatment. Tumor-targeting HVJ-E was also developed. Thus, HVJ-E will be a novel promising tool for cancer treatment.